Why the study?
The effect of thiazide diuretic therapy and diuretic-induced hypokalemia on ventricular arrhythmias in patients with systemic hypertension was uncertain.
Does hydrochlorothiazide increase ventricular ectopy in patients with uncomplicated systemic hypertension?
Cohort (n=44)
Does hydrochlorothiazide increase ventricular ectopy in patients with uncomplicated systemic hypertension?
Hydrochlorothiazide therapy at 100 mg daily for 4 weeks does not increase ventricular ectopy in patients with uncomplicated systemic hypertension, even in those who develop hypokalemia or have left ventricular hypertrophy.
Supports short-term hydrochlorothiazide safety regarding ectopy in uncomplicated hypertension; leaves open arrhythmia risks with longer use or higher-risk groups.
• Forty-four patients with uncomplicated systemic hypertension underwent 48-hour electrocardiographic monitoring before and after four weeks of treatment with hydrochlorothiazide, 100 mg daily. Plasma potassium concentration decreased from 4.07±0.26 mmol/L (4.07±0.26 mEq/L) to 3.36±0.44 mmol/L (3.36 ±0.44 mEq/L). The average number of premature ventricular contractions, couplets, or ventricular tachycardia episodes did not change significantly. Twenty patients had more than minimal ventricular ectopy (class 2 to 5) before and 17 after diuretic therapy. Further analysis revealed that following diuretic therapy, neither patients with plasma potassium levels of 3.4 mmol/L or less (≤3.4 mEq/L) nor patients with left ventricular hypertrophy had increased ectopy as compared with baseline. At baseline, patients with left ventricular hypertrophy had more arrhythmias than patients without. We conclude that the results of this study provide no evidence that diuretic therapy or diuretic-induced hypokalemia results in increased ventricular ectopy, and that patients with left ventricular hypertrophy may have more ventricular ectopy than patients without, but these arrhythmias are not adversely effected by diuretic therapy. (Arch Intern Med1988;148:1272-1276)
No takes yet. Share an insight, caveat, or question.
V. Papademetriou (1988) conducted a cohort in Systemic hypertension (n=44). Hydrochlorothiazide vs. Baseline was evaluated on More than minimal ventricular ectopy (class 2 to 5).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: